Light Rain Fog/Mist 45°
Tag:

FDA Center for Biologics Evaluation and Research

News
CDC, FDA Call For Pause On Johnson & Johnson Vaccine CDC, FDA Call For Pause On Johnson & Johnson Vaccine
CDC, FDA Call For Pause On Johnson & Johnson Vaccine The US Centers for Disease Control and Prevention and the US Food and Drug Administration are calling for a pause on the use of Johnson & Johnson's COVID-19 vaccine due to six cases of "rare and severe" blood clot cases reported. All six cases occurred among women between 18 and 48, and symptoms occurred 6 to 13 days after vaccination, FDA officials said in a joint statement. More than 6.8 million doses of the one-dose vaccine had been administered in the U.S. All Pennsylvania teachers and administrators were given the J&J vaccine. Out of the 200,000 offered the vaccine a…

SHARE

by Cecilia Levine